Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy

Biochemical Pharmacology

Volumn 57, Issue 3, 1999, Pages 309-312

  Raghunand, Natarajan ^a   Altbach, Maria I ^a   Van Sluis, Robert ^a   Baggett, Brenda ^a   Taylor, Charles W ^a   Bhujwalla, Zaver M ^b   Gillies, Robert J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 Aminopropylphosphonate; 31P magnetic resonance spectroscopy; Breast carcinoma; MCF 7; Tumor pH; Xenograft

Indexed keywords

DOXORUBICIN; MITOXANTRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELL MEMBRANE; CELL PH; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; CELL MEMBRANE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PHOSPHORUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032927078     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00306-2     Document Type: Article

References (16)

1. Taylor C.W., Dalton W.S., Mosley K., Dorr R.T., Salmon S.E. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer. Breast Cancer Res Treat. 42:1997;7-14.
2. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49:1989;4373-4384.
3. Roepe P.D. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry. 31:1992;12555-12564.
4. Simon S., Roy D., Schindler M. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA. 91:1994;1128-1132.
5. Gerweck L.E., Seetharaman K. Cellular pH gradient in tumor versus normal tissue: Potential for exploitation for the treatment of cancer. Cancer Res. 56:1996;1194-1198.
6. Wike-Hooley J.L., Haveman J., Reinhold H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol. 2:1984;343-366.
7. 31P MRS as a method of measuring pH in rat tumours. NMR Biomed. 5:1992;351-359.
8. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol. 267:1994;C195-C203.
9. Taylor C.W., Dalton W.S., Parrish P.R., Gleason M.C., Bellamy W.T., Thompson F.H., Roe D.J., Trent J.M. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer. 63:1991;923-929.
10. Taetle R., Rosen F., Abramson I., Venditti J., Howell S. Use of nude mouse xenografts as preclinical drug screens In vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts . Cancer Treat Rep. 71:1987;297-304.
11. Kimmich R., Hoepfel D. Volume-selective multipulse spin-echo spectroscopy. J Magn Reson. 72:1987;379-384.
12. Ordidge R.J., Bowley R.M., McHale G. A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn Reson Med. 8:1988;323-331.
13. 31P magnetic resonance spectroscopy in murine tumors. Br J Cancer. 72:1995;905-911.
14. Gillies R.J., Alger J.R., den Hollander J.A., Shulman R.G. Intracellular pH measured by NMR Methods and results . Nuccitelli R., Deamer D.W. Intracellular pH Its Measurement, Regulation, and Utilization in Cellular Functions . 1982;79-104 Alan R. Liss, New York.
15. 31P-NMR spectrum. Am J Physiol. 266:1994;R638-R645.
16. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.